Subacute thyroiditis after SARS-CoV2 vaccine: possible relapse after boosting.

Teti, C; Nazzari, E; Graziani, G; Bagnasco, M

Teti, C; Nazzari, E; Graziani, G; Bagnasco, M.

Afiliación

Teti C; Endocrinology, Diabetology and Metabolic Diseases Unit, ASL1, Imperia, Italy. claudia.teti@yahoo.it.
Nazzari E; BNT Endocrinology Unit, JB Medica, Genoa, Italy. claudia.teti@yahoo.it.
Graziani G; Endocrinology and Diabetology Unit, ASL2, Savona, Italy.
Bagnasco M; BNT Endocrinology Unit, JB Medica, Genoa, Italy.

J Endocrinol Invest ; 45(10): 2019-2020, 2022 10.

Article en En | MEDLINE | ID: mdl-35790684

Asunto(s)

COVID-19; Tiroiditis Subaguda; Vacunas; COVID-19/prevención & control; Humanos; ARN Viral; Recurrencia; SARS-CoV-2; Tiroiditis Subaguda/etiología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tiroiditis Subaguda / Vacunas / COVID-19 Tipo de estudio: Etiology_studies Idioma: En Revista: J Endocrinol Invest Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google